Severe malaria treatment receives FDA approval
Outbreak News27 Mai 2020

Severe malaria treatment receives FDA approval

Approximately 2,000 US cases of malaria are diagnosed annually. Without appropriate treatment, about 15 percent become severe. Mortality from untreated severe malaria (particularly cerebral malaria) approaches 100 percent.

On Tuesday, the Food and Drug Administration (FDA) approved Artesunate for Injection to Amivas, a Maryland company specializing in treatments for rare and neglected tropical diseases.

Joining me today to talk about severe malaria and the newly approved drug is Bryan Smith, MD. Dr. Smith is the Chief Medical Officer at Amivas.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(535)

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
aftenpodden-usa
popradet
forklart
fotballpodden-2
stopp-verden
rss-gukild-johaug
det-store-bildet
nokon-ma-ga
rss-espen-lee-usensurert
lydartikler-fra-aftenposten
dine-penger-pengeradet
hanna-de-heldige
rss-ness
aftenbla-bla
frokostshowet-pa-p5
rss-penger-polser-og-politikk
e24-podden
liverpoolno-pausepraten